No Data
No Data
Strong Financial Performance and Strategic Initiatives Justify Buy Rating for WELL Health Technologies Corp
Well Health Technologies Corp Price Target Raised to C$5.25/Share From C$5.00 by CIBC World Markets
Press Release: WELL Health Achieves $1 Billion Annualized Revenue Run-Rate Ahead of Plan With Best Ever Quarterly EBITDA and Free Cashflow Results for Q3-2024 and Raises Annual Revenue Guidance
WELL Health Brief: Moves To Acquire Canadian Clinical Assets of Jack Nathan Health and Begin Operating Clinics in Wal-Mart Stores to Grow Healthcare Clinic Network Across Canada
2 Undervalued Canadian Stocks to Buy Now
Well Health Technologies Corp. Is Maintained at Buy by Ventum Financial
No Data